Miura Global Management’s Cytek Biosciences CTKB Stock Holding History

Miura Global Management’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-380,591	Closed	-$3.25M	–	22
2023 Q2	$3.25M	Sell	380,591 -55,309	-13%	-$496K	1.16%	19
2023 Q1	$4.01M	Sell	435,900 -344,100	-44%	-$3.7M	2.33%	18
2022 Q4	$7.96M	Sell	780,000 -40,000	-5%	-$538K	4.01%	12
2022 Q3	$12.1M	Sell	820,000 -829,400	-50%	-$10.8M	7.23%	5
2022 Q2	$17.7M	Sell	1,649,400 -605,600	-27%	-$6.03M	12.14%	2
2022 Q1	$24.3M	Sell	2,255,000 -765,000	-25%	-$10.3M	7.9%	2
2021 Q4	$49.3M	Buy	3,020,000 +902,500	+43%	+$18.9M	8.35%	3
2021 Q3	$45.3M	Buy	+2,117,500	New	+$49.8M	7.03%	3

Other funds holding CTKB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Miura Global Management's CTKB Position: Q3 2023 in Review

Miura Global Management sold out of Cytek Biosciences (CTKB) in Q3 2023, closing a stake of 380,591 shares — an estimated $3.25M sold.

Miura Global Management first reported a position in CTKB in Q3 2021 and held it in 8 quarters. The position peaked at $49.3M in Q4 2021. 106 funds tracked by Wall St. Rank hold CTKB as of Q3 2023.

Miura Global Management reported no remaining Cytek Biosciences position as of Q3 2023 after selling out during the quarter.
Miura Global Management sold 380,591 Cytek Biosciences shares in Q3 2023, an estimated $3.25M.
Miura Global Management first reported a position in Cytek Biosciences in Q3 2021 and held it in 8 quarters.
Miura Global Management's Cytek Biosciences position peaked at $49.3M in Q4 2021.
106 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2023.

Based on Miura Global Management's 13F filing for Q3 2023, filed 13 Nov 2023.